LC-PDA-QTof-MS characterization of the stress degradation products of Zanubrutinib: A novel BTK inhibitor
- 9 September 2023
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 236, 115714
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- An Overview - International Conference on Harmonisation and ICH (Q1) Stability Testing Guideline for Pharmaceutical DevelopmentInternational Journal for Research in Applied Science and Engineering Technology, 2019
- Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 TrialBlood, 2018
- Identification of related substances in tofacitinib citrate by LC-MS techniques for synthetic process optimizationJournal of Pharmaceutical and Biomedical Analysis, 2017
- Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitorJournal of Pharmaceutical and Biomedical Analysis, 2016
- Molecular pathogenesis of mantle cell lymphomaJournal of Clinical Investigation, 2012
- Thermal behaviour of fentanyl and its analogues during flash pyrolysisJournal of Thermal Analysis and Calorimetry, 2009
- Neutral loss of isocyanic acid in peptide CID spectra: A novel diagnostic marker for mass spectrometric identification of protein citrullinationJournal of the American Society for Mass Spectrometry, 2008
- Acid catalyzed 1, 2 Michael addition reaction: a viable synthetic route in designing fullerene core starlike macromoleculeJournal of Physical Organic Chemistry, 2008
- Study of michael-michael-retro michael addition catalyzed by 9-amino-9-deoxyepiquinine using ESI-MSJournal of the American Society for Mass Spectrometry, 2007
- Experimental thermochemical study of three monosubstituted pyrazinesThe Journal of Chemical Thermodynamics, 2005